Spread pricing, rebates and vertical integration has created structure in drug distribution that's incentivized the increase in prices to the end point consumer. In today's episode we follow the money. We look at states that have legally paid hundreds of millions of dollars from their medicaid coffers to PBM's because of spread pricing. We look at medications that cost multiples more in the US versus Europe because of rebates. We look at the vertical octopus that has resulted in the US paying WAY more than anywhere else in the world for our drugs. A process, by the way, written into the contracts...